以脂肪酸合成酶FabH为靶标的化合物体外抗结核作用的初步研究

中国防痨杂志 ›› 2007, Vol. 29 ›› Issue (2): 147-150.

以脂肪酸合成酶FabH为靶标的化合物体外抗结核作用的初步研究

吴雪琼¹；张学辉²；张俊仙¹；龙隆²；于红²；陆阳¹；王莉莉²；李松²；

1解放军总医院第二附属医院结核病研究室北京 100091；；2军事医学科学院毒物药物研究所北京 100850；

出版日期:2007-02-10 发布日期:2007-11-03
基金资助:
国家973计划项目(2004CB518908);;军队医学“十一五”科研基金项目(06MA272)

The study on antimycobacterial activities in vitro of the compounds that target Mycobacterium tuberculosis fabH

Wu Xueqiong¹,Zhang Xuehui,Zhang Junxian,et al.

1.Tuberculosis Research Laboratory,Tuberculosis Center,the Second Affiliated Hospital,Chinese PLA General Hospital,Beijing 100091,China

Online:2007-02-10 Published:2007-11-03

摘要/Abstract

摘要： 目的研究结核分枝杆菌脂肪酸合成酶FabH为靶标的化合物的体外抗结核活性,研制新的高效、安全的抗结核药物。方法以平板滤纸法测定化合物对草分枝杆菌的抑菌圈,以试管抑菌法检测化合物对结核分枝杆菌药物敏感株和耐多药分离株的抑制作用。结果18种化合物在500μmol/L浓度时对草分枝杆菌的抑菌圈为1.82.4 cm,其中7种化合物在250μmol/L和125μmol/L浓度时对草分枝杆菌的抑菌圈为1.52.2 cm。结核分枝杆菌H₃₇Rv标准株在分别含3mmol/L的18种化合物的培养基上培养2周时,绝大多数含化合物培养基上未见细菌生长;培养4周时,No.115、No.131、No.128、No.129、No.137化合物的抑菌作用较明显。结核分枝杆菌耐多药分离株HB240在分别含3mmol/L的11种化合物的培养基上培养2周和4周时,No.115化合物均显示明显的抑菌作用。结论以脂肪酸合成酶FabH为靶标的大多数化合物在体外都具有不同程度的抗结核活性,尤其是No.115化合物对草分枝杆菌、结核分枝杆菌敏感株和耐药株都具有明显的抑制作用。

关键词: FabH,脂肪酸合成酶, β-酮酰基-酰基运载蛋白合成酶Ⅲ, 抗结核作用, 分枝杆菌,结核

Abstract: Objective To study antimycobacterial activities in vitro of the compounds that target Mycobacterium tuberculosis β-ketoacyl-acyl carrier protein(ACP) synthase Ⅲ(FabH),and to obtain a novel,effective,and safe antituberculous agent. Methods The inhibitory diameters of compounds effect on M.phlei on agar plate were determined.The inhibitory effect of compounds on M.tuberculosis strain H37Rv and MDR-strain was tested on L-J media. Results The inhibitory diameters of 18 kinds of 500μmol/L compounds effect on M.phlei on agar plate were 1.8 to 2.4cm,respectively.The inhibitory diameters of 7 kinds of 250μmol and 125μmol compounds effect on M.phlei on agar plate were 1.5 to 2.2cm,respectively.18 kinds of 3mmol/L compounds inhibited obviously the growth of M. tuberculosis strain H₃₇R_v on L-J media at 2 weeks,and the compounds No.115, No.131,No.128,No.129,and No.137 also inhibited at 4 weeks.The compounds No.115 exhibited obvious inhibitory activity on M.tuberculosis MDR-strain HB240 inoculated on L-J media containing 11 kinds of compounds for 2 weeks and 4 weeks,respectively. Conclusion The most of compounds targeted fatty acid synthase FabH exhibited different degree of antimycobacterial activities,especially compounds No.115 had obvious inhibitory effect on M.phlei,M.tuberculosis strain H₃₇R_v and MDR-strain HB240.

Key words: FabH, Fatty acid synthase, β-ketoacyl-acyl carrier protein synthase Ⅲ, Antimycobacterial activity, Mycobacterium tuberculosis

吴雪琼,张学辉,张俊仙,龙隆,于红,陆阳,王莉莉,李松,. 以脂肪酸合成酶FabH为靶标的化合物体外抗结核作用的初步研究[J]. 中国防痨杂志, 2007, 29(2): 147-150.

Wu Xueqiong¹,Zhang Xuehui,Zhang Junxian,et al.. The study on antimycobacterial activities in vitro of the compounds that target Mycobacterium tuberculosis fabH[J]. Chinese Journal of Antituberculosis, 2007, 29(2): 147-150.

[1]	高凌玉,张健源,李传友,周建琴,游雪甫,王振,汪月,孙承航,. 康乐霉素A体外抗结核活性的初步研究[J]. 中国防痨杂志, 2007, 29(2): 160-162.
[2]	吴风霞,李慧灵,王鑫君,. 结核分枝杆菌L型检测的临床意义[J]. 中国防痨杂志, 2004, 26(2): 107-109.